drugset / Trial / NCT01177514

The Role of Gabapentin in Postoperative Pain and Epithelialization After Photorefractive Keratectomy

NCT01177514

Phase 4 Completed 40 enrolled Codet Vision Institute
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The primary aims of this study are to determine if treatment with Gabapentin taken systemically (oral tablets) in patients who have photorefractive keratectomy (PRK) surgical treatments reduces post surgical neuropathic pain and discomfort. The investigators main Hypothesis is that gabapentin given prior to and after refractive surgery prevents central sensitization and local allodynia.

Timeline

Start
2010-04
Primary completion
2010-09
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 300 mg Oral

Indications

No indication recorded.